Certara Services Archives

White Paper

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Since 2019, the Institute for Clinical and Economic Review (ICER) has published an annual Unsupported…

CertaraJuly 25, 2023

Case Study

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

CertaraJune 1, 2023

Conference

American College of Toxicology 2025 Annual Meeting

– – Booth

CertaraMay 24, 2023

Conference

ISPOR Europe 2025

–

CertaraMay 24, 2023

Conference

ACoP 2025

CertaraMay 24, 2023

Case Study

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…

CertaraMay 9, 2023

Case Study

Using MBMA to run virtual “head-to-head trials”

Osteoporosis is common in post-menopausal women. The long-term sequelae of osteoporosis include bone fractures, particularly…

CertaraApril 21, 2023

Conference

AMWA 2025 Medical Writing and Communications Conference

–

CertaraApril 20, 2023

Case Study

Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial

Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…

CertaraApril 17, 2023

Case Study

Using Real World Evidence to Inform Treatment Guidelines

Real-World Evidence (RWE) has become increasingly valuable in informing the development of treatment guidelines for…

CertaraApril 5, 2023

Certara Services

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program

American College of Toxicology 2025 Annual Meeting

ISPOR Europe 2025

ACoP 2025

Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease

Using MBMA to run virtual “head-to-head trials”

AMWA 2025 Medical Writing and Communications Conference

Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial

Using Real World Evidence to Inform Treatment Guidelines

Newsletter sign up

Quick links

Solutions

Contact